Drug and Neurotransmitter Receptors: New Perspectives With Clinical Relevance

Research output: Contribution to journalArticlepeer-review

Abstract

Our understanding of drug and neurotransmitter receptors has been greatly advanced by receptor binding techniques. The theme of multiple-receptor subtypes with clinical relevance is highlighted by calcium antagonist and benzodiazepine receptors. Numerous drugs may exert therapeutic and untoward effects via calcium channels. Examples include effects of loperamide hydrochloride on diarrhea, the phenothiazine thioridazine hydrochloride on cardiac and ejaculatory function, and the neuromuscular toxicity of aminoglycosides. Elevated numbers of calcium antagonist receptors in hypertrophic cardiomyopathy may be involved in the pathophysiology of this disease. Benzodiazepines act via discrete central and peripheral receptors. At central receptors, benzodiazepines facilitate the inhibitory effects of the neurotransmitter -y-aminobutyric acid. Peripheral benzodiazepine receptors are localized to mitochondria and enriched in several endocrine glands where they are influenced by therapeutic blood levels of benzodiazepines such as diazepam.

Original languageEnglish (US)
Pages (from-to)3126-3129
Number of pages4
JournalJAMA: The Journal of the American Medical Association
Volume261
Issue number21
DOIs
StatePublished - Jun 2 1989

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Drug and Neurotransmitter Receptors: New Perspectives With Clinical Relevance'. Together they form a unique fingerprint.

Cite this